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Alcohol consumption and risk of lung cancer:
a pooled analysis of cohort studies1–3
Jo L Freudenheim, John Ritz, Stephanie A Smith-Warner, Demetrius Albanes, Elisa V Bandera, Piet A van den Brandt,
Graham Colditz, Diane Feskanich, R Alexandra Goldbohm, Lisa Harnack, Anthony B Miller, Eric Rimm,
Thomas E Rohan, Thomas A Sellers, Jarmo Virtamo, Walter C Willett, and David J Hunter
ABSTRACT
Background: Although smoking is the primary cause of lung can-
cer, much is unknown about lung cancer etiology, including risk
determinants for nonsmokers and modifying factors for smokers.
Objective: We hypothesized that alcohol consumption contributes
to lung cancer risk.
Design: We conducted a pooled analysis using standardized expo-
sure and covariate data from 7 prospective studies with 399 767
participants and 3137 lung cancer cases. Study-specific relative risks
(RRs) and CIs were estimated and then combined to calculate pooled
multivariate RRs by using a random-effects model.
Results: We found a slightly greater risk for the consumption of30
g alcohol/d than for that of 0 g alcohol/d in men (RR: 1.21; 95% CI:
0.91, 1.61; P for trend  0.03) and in women (RR: 1.16; 95% CI:
0.94, 1.43; P for trend  0.03). In male never smokers, the RR for
consumption of15 g alcohol/d rather than 0 g alcohol/d was 6.38
(95% CI: 2.74, 14.9; P for trend 0.001). In women, there were few
never-smoking cases and no evidence of greater risk (RR: 1.35; 95%
CI: 0.64, 2.87). Because of possible residual confounding by smok-
ing, we performed sensitivity analyses by reclassifying the never
smokers in the highest drinking category as former smokers. Result-
ing associations for alcohol consumption were somewhat attenu-
ated, but P for trend  0.05 for men, which was near the original
P 0.03.
Conclusions: A slightly greater risk of lung cancer was associated
with the consumption of 30 g alcohol/d than with no alcohol
consumption. Alcohol consumption was strongly associated with
greater risk in male never smokers. Residual confounding by smok-
ing may explain part of the observed relation. Am J Clin Nutr
2005;82:657–67.
KEY WORDS Alcohol consumption, diet, epidemiology,
lung neoplasms, meta-analysis
INTRODUCTION
There is clear evidence that smoking causes lung cancer, but
much about the etiology of lung cancer is not well understood,
including why some nonsmokers develop lung cancer and why
only a portion of smokers do so. It has been suggested that some
of this variation may be explained by alcohol consumption (1, 2).
Alcohol is oxidized to acetaldehyde, a known carcinogen (3).
There is evidence that alcohol can act as a prooxidant in tissues,
including lung tissue (4–12), and on lipids, including lung mem-
brane lipids (4, 13). Alcohol can induce the expression of en-
zymes that are related to carcinogen metabolism (14), and com-
pounds other than ethanol that are contained in alcoholic
beverages may have carcinogenic effects.
In studies of alcoholics, morbidity and mortality due to lung
cancer have been shown to be high (15–21), but the greater risk
may be explained, in part or entirely, by the fact that the people
in these populations were also more likely to smoke. Most studies
of alcoholics have not controlled for the smoking status of par-
ticipants. In studies measuring both alcohol consumption and
smoking in individuals, there is some (although inconsistent)
evidence of a modest increase in lung cancer risk in association
with alcohol consumption (2, 22). In a meta-analysis, there was
evidence of a greater risk of lung cancer associated with heavier
drinking in cohort and hospital-based case-control studies but not
in population-based case-control studies (22). Many studies ex-
amining alcohol and lung cancer have been limited by small
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sample size, particularly with respect to heavy drinkers. Further-
more, given the correlation between alcohol consumption and
smoking, the examination of the effect of alcohol in never smok-
ers is particularly informative. However, most studies have not
been able to examine risk in this group because of the small
numbers of lung cancer cases identified in never smokers. In the
Pooling Project of Prospective Studies of Diet and Cancer (23-
25), the primary data from 7 cohort studies of diet and cancer
have been reanalyzed by using standardized categories of alcohol
consumption and of all potential covariates including the smok-
ing variables. These data allow for the examination of subgroups
of interest to address the issue of a possible association of alcohol
consumption with lung cancer. We report here pooled results
from these cohorts with respect to the association between alco-
hol consumption and the risk of lung cancer.
SUBJECTS AND METHODS
Methods for the Pooling Project of Prospective Studies of Diet
and Cancer have been described previously (23–25). The Pool-
ing Project was originally designed to examine associations be-
tween dietary factors and breast cancer risk. It has now been
expanded to include analyses related to other cancer sites, and it
therefore includes cohorts of men. Inclusion criteria for cohort
studies in the pooled analyses of lung cancer were50 incident
cases of lung cancer, an assessment of usual diet, a validation
study of the diet instrument or of a closely related instrument, and
assessment of smoking status at baseline. For these analyses
related to lung cancer, 2 cohorts included previously in the breast
cancer analyses [the New York University Women’s Health
Study (26) and the Swedish Mammography Cohort (27)] were
not included because smoking data were not collected at base-
line. In addition, as in the previous study of alcohol and breast
cancer (24), the Adventist Health Study (28) was not included
because of the low prevalence of alcohol consumption in that
population. Each of the studies included here had been reviewed
and approved by the institutional review board of the institution
at which the study was conducted.
As shown in Table 1, included in this report were 5 cohorts
with women [the Canadian National Breast Screening Study
(29), the Iowa Women’s Health Study (1), the Netherlands Co-
hort Study (30), the New York State Cohort (31), and the Nurses’
Health Study (NHS; 32, 33)] and 4 cohorts with men [the
-Tocopherol -Carotene Cancer Prevention Study (ATBC;
34), the Health Professionals Follow-up Study (32, 33), the Neth-
erlands Cohort Study (30), and the New York State Cohort (31)].
Because there were repeated assessments of smoking and alcohol
consumption for the NHS, this cohort has been analyzed in 2
sections: NHS Section A, including the 1980–1986 follow-up,
and NHS Section B, including the 1986–1996 follow-up. Inci-
dent cases from the NHS were counted in just one of the cohorts
(although a woman could contribute person-time as a noncase to
NHS Section A and become a case in NHS Section B). Because the
person-time in the different time periods was asymptotically uncor-
related even though the data were based on the same participants
(35), the use of pooled estimates from the 2 time periods did not
differ from the use of estimates from a single time period but had the
advantage of using the updated exposure data from 1986.
Lung cancer outcome ascertainment
Each study ascertained incident lung cancers by using
follow-up questionnaires with subsequent medical record review
TABLE 1
Characteristics of the cohort studies included in the pooled analysis of alcohol and lung cancer
Study
Follow-up
period
Baseline cohort
size1
Age
range
Lung cancer
cases
Alcohol intake
in drinkers2 Drinkers
n y n g/d %
Alpha-Tocopherol Beta-Carotene Cancer Prevention
Study, men
1985–1996 67713 50–69 298 20.2 21.8 89
Canadian National Breast Screening Study, women 1980–1993 56 837 40–59 149 10.9 14.5 77
Health Professionals Follow-Up Study, men 1986–1996 44 349 40–75 244 14.8 16.1 76
Iowa Women’s Health Study, women 1986–1996 33 831 55–69 433 8.7 12.3 45
Netherlands Cohort Study
Women 1986–1992 62 412 55–69 128 8.5 10.6 68
Men 1986–1992 58 279 55–69 828 17.1 16.6 85
New York State Cohort
Women 1980–1987 21 045 15–107 130 6.0 9.4 78
Men 1980–1987 27 936 15–107 392 12.1 17.0 89
Nurses’ Health Study, women
Section A 1980–1986 88 307 34–59 156 9.4 11.6 68
Section B 1986–1996 68 3074 40–65 379 9.6 12.0 64
Total 399 767 3137
1 After exclusion of participants with incomplete alcohol intake data, implausible values for energy intake, or previous diagnosis of cancer (other than
nonmelanoma skin cancer). Participants were also excluded if data regarding smoking status, smoking duration (for current and past smokers), or smoking dose
(for current smokers) were missing.
2 x  SD. In the United States, there is 12.8 g alcohol in 12 oz (335 mL) beer, 10.9 g alcohol in 4 oz (118 mL) wine, and 14.0 g alcohol in 1.5 oz (44 mL)
80-proof spirits.
3 Only the placebo group of the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study was included.
4 The participants in the baseline cohort for the Nurses’ Health Study Section B are included in the Nurses’ Health Study Section A and are not included
in the total.
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(32), linkage with a cancer registry (1, 29–31) or both (34). In
addition, some studies used mortality registries or death certifi-
cates (1, 29, 31, 32, 34). We categorized lung cancer on the basis
of the International Classification of Diseases for Oncology mor-
phology codes (36) or the histologic classification provided by
the original study investigators.
Alcohol consumption assessment
For most of the cohorts, alcohol consumption was assessed
with queries regarding the consumption of beer, wine, and spirits.
Some of the questionnaires included information regarding red
and white wine or other specific beverages. For the New York
State Cohort, only total alcohol consumption was queried; this
cohort was not included in beverage-specific analyses. The for-
mat of the questionnaires varied. Some allowed participants to
indicate both frequency of drinking and the usual number of
drinks on each occasion; others asked participants to choose
among categories indicating total usual alcohol consumption.
Most of the questionnaires assumed a standard drink size; the
Canadian National Breast Screening Study allowed participants
to indicate a drink size that differed from the standard indicated,
and the ATBC Study allowed participants to choose from 1 of 3
portion-size options. Alcohol consumption in grams per day was
calculated for each study by using the reported frequency of
consumption, the beverage-specific alcohol content, and the av-
erage amount consumed.
Smoking assessment
For each cohort, baseline cigarette smoking status (never, cur-
rent, or former smoker) was assessed. The ATBC Study (34) was
limited by design to men who were currently smokers. For all of
the cohorts, data were also obtained regarding duration of smok-
ing in those who had ever smoked. For most studies, the infor-
mation about the amount smoked was the amount of smoking at
baseline. For the New York State Cohort, the usual number of
cigarettes smoked daily was ascertained. Because few of the
studies included questions regarding pipes, cigars, and other
tobacco products, only cigarette smoking was considered here.
Only the Netherlands Cohort Study included a detailed assess-
ment of passive smoking.
Statistical analysis
For each dataset, after applying the exclusion criteria used by
that study, we further excluded participants if they reported a
history of cancer (other than nonmelanoma skin cancer) at base-
line, were missing information regarding alcohol consumption,
reported energy intakes either  or  3 SDs from the study-
specific loge-transformed mean energy intake of the baseline
population, or were lacking information on smoking status, the
number of years of smoking by past and current smokers, or the
number of cigarettes smoked daily by current smokers.
We examined risk related to alcohol consumption by using the
Cox proportional hazards model (37). Relative risks (RRs) were
estimated for categories of total alcohol consumption and for
consumption of alcohol from beer, wine, and spirits. P for trend
across categories was calculated by taking the study-specific
median for each category and assigning that value to all the
participants in that category. This variable was then entered into
the regression model.
Incidence rate ratios for the ATBC Study, the Health Profes-
sionals Follow-up Study, the Iowa Women’s Health Study, the
New York State Cohort, and the NHS were estimated by using
SAS PROC PHREG software (version 8.2; SAS Institute, Cary,
NC; 38). For the Canadian National Breast Screening Study and
the Netherlands Cohort Study, the analysis was of a case-cohort
study (39) and used EPICURE software (version 2.11; Hirosoft,
Seattle, WA; 40). In all the studies, age at baseline and the year
that the baseline questionnaire was returned were included as
stratification variables. Person-years of follow-up were calcu-
lated from the date the baseline questionnaire was returned until
the date of lung cancer diagnosis, the date of death, or the end of
follow-up, whichever came first.
We compared the following approaches for controlling for
confounding by smoking: adjustment for smoking status, adjust-
ment for pack-years smoked, adjustment for smoking status and
duration of smoking, and adjustment for smoking status, duration
of smoking, and amount smoked. Of these, the last model (ie,
smoking status, duration of smoking, and amount smoked) ex-
plained more of the variation in risk than did the others, and it is
the one reported here.
Because of differences between men and women in the distri-
bution of alcohol consumption and of beverage-specific use, we
conducted sex-specific analyses. For the cohorts that included
both men and women, ie, the Netherlands Cohort Study and New
York State Cohort, men and women from each cohort were
analyzed separately. All RRs were adjusted for smoking status
(never, past, or current), smoking duration (for past and current
smokers; continuous), amount smoked (for current smokers;
continuous), education (high school graduate, high school
graduate, orhigh school graduate), body mass index (in kg/m2)
(23, 23 to 25, 25 to 30, or 30), and energy intake (con-
tinuous). We had previously found fruit intake and
-cryptoxanthin to be inversely associated with the risk of lung
cancer (25, 41). We examined confounding by both of these
factors but found that results were very similar with and without
inclusion of either the fruit or -cryptoxanthin variable; results
reported here are without adjustment for either of these dietary
variables. An indicator variable for missing responses for covari-
ates was created, when applicable. There was missing informa-
tion for7% of participants for each variable within each study.
Two-sided 95% CIs and P values were calculated. We used the
random-effects model to combine the loge RRs; study-specific
RRs were weighted by the inverse of their variance (42).
Heterogeneity among studies was calculated by using the Q
statistic (42, 43). For analysis of associations between specific
types of alcoholic beverages and lung cancer, a test for between-
study heterogeneity was carried out simultaneously on all alco-
holic beverages (beer, wine, and spirits); the results were not
statistically significant. A contrast test based on the beverage-
specificassociationsandtheirestimatedcovariancematrixwasused
to test for differences between the associations. This test statistic
approximately follows a chi-square distribution with 2 df.
For total alcohol consumption, risk was calculated according
to strata of smoking status and several dietary variables. We
examined analyses stratified by intake of fruit and of
-cryptoxanthin because of the previous finding that each was
inversely associated with risk of lung cancer in the Pooling
Project (25, 41). We examined risks within strata of folate intake
because of interactions between folate and alcohol at the level of
absorption and metabolism (44) and examined risks within strata
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of vitamin A intake because of previous findings of differences
in risk associated with alcohol depending on vitamin A status
(45). We tested whether there were differences in the RRs be-
tween the strata by using a meta-regression model (46). We also
tested whether associations differed between adenocarcinomas,
small cell carcinomas, and squamous cell carcinomas by using a
2-df Wald test statistic (47). Collectively, these 3 histologic types
represented60% of the cases in each study.
RESULTS
This study included 7 cohorts with 399 767 participants and
3137 lung cancer cases (1375 females and 1762 males) (Table 1).
Drinking rates varied among the cohorts. Mean drinking was
highest in the ATBC Study and lowest in the cohorts of women.
The Iowa Women’s Health Study had the largest percentage who
reported being nondrinkers (55%). Nearly half of the male cases
were members of the Netherlands Cohort Study. Among the
female cases, the largest number came from the Iowa Women’s
Health Study and the NHS.
As shown in Table 2, there was a tendency for the prevalence
of smoking to increase with greater alcohol consumption; the
proportion of never smokers decreased and that of current smok-
ers increased. However, the amount smoked by smokers was
similar in each category although somewhat higher for the high-
est category of alcohol. The one exception was the ATBC Study,
which was limited to smokers, such that, at every level of alcohol
consumption, 100% of the subjects were smokers. The correla-
tion between alcohol consumption in drinkers and cigarettes
smoked daily in current smokers ranged from 0.09 in the females in
the New York State Cohort to 0.24 in the subjects (all of whom were
male) of the ATBC Study; the median correlation in the cohorts was
0.16, and all correlations were significant (data not shown).
Study-specific and pooled multivariate RRs of lung cancer in
relation to alcohol consumption are shown in Table 3. In models
adjusted only for age, the pooled RRs for consumption of30 g
alcohol/d compared with no alcohol consumption were 1.76
(95% CI: 1.15, 2.67) in men and 3.09 (95% CI: 2.06, 4.63) in
women. In multivariate models that included adjustment for
smoking, the pooled RRs associated with reported consumption
of30 g alcohol/d compared with no alcohol consumption were
1.21 (95% CI: 0.91, 1.61) in men and 1.16 (95% CI: 0.94, 1.43)
in women; neither of these values was statistically significant.
For both men and women, the test for trend in this association was
statistically significant (P 0.03). The heterogeneity by sex was
not statistically significant (P 0.72 for between-studies heter-
ogeneity due to sex for 30 g alcohol/d category); the pooled
estimate for men and women combined was 1.18 (95% CI: 1.00,
1.39) in a comparison of consumption of30 and 0 g alcohol/d
(data not shown). Among the men, when the analysis excluded
those cases diagnosed within 4 y of the baseline data collection,
the pooled multivariate RR for the upper category of consump-
tion was 1.48 (95% CI: 0.96, 2.29; P for trend  0.02). There
was significant heterogeneity among the cohorts for this analysis
(P 0.04). In the corresponding analysis in women, the RR was
slightly closer to the null than it was when all cases were in-
cluded; the results were not statistically significant (pooled mul-
tivariate RR: 1.06; 95% CI: 0.83, 1.35; P for trend 0.16).
TABLE 2
Smoking habits by alcohol consumption category and by study1
Men Women
ATBC HPFS NLCS NYSC CNBSS IWHS NLCS NYSC NHS-A NHS-B
Alcohol consumption
0 g/d
Never smokers (%) 0 62 22 44 63 75 73 71 57 57
Current smokers (%) 100 7 33 16 17 11 15 13 22 17
Cigarettes smoked/d (n)2 20 93 22 12 16 9 25 13 19 11 19 10 12 8 20 11 21 10 20 11
0 to5 g/d
Never smokers (%) 0 54 20 34 57 66 68 52 45 45
Current smokers (%) 100 7 27 18 18 13 16 21 27 19
Cigarettes smoked/d (n)2 18 8 20 12 16 7 23 12 18 8 18 9 12 7 19 11 19 10 19 10
5 to15 g/d
Never smokers (%) 0 45 16 27 47 48 44 35 33 33
Current smokers (%) 100 9 28 20 20 23 26 31 33 24
Cigarettes smoked/d (n)2 19 8 20 12 15 8 23 12 18 9 18 10 12 8 19 12 19 11 19 11
15 to30 g/d
Never smokers (%) 0 38 7 22 35 38 33 22 27 27
Current smokers (%) 100 9 39 25 27 26 32 42 35 26
Cigarettes smoked/d (n)2 21 8 19 12 16 9 24 12 18 10 19 10 15 10 19 11 20 11 19 10
30 g/d
Never smokers (%) 0 25 6 15 29 22 15 16 18 19
Current smokers (%) 100 20 43 36 33 51 55 52 54 43
Cigarettes smoked/d (n)2 24 10 23 13 19 11 28 13 19 10 23 11 15 9 23 12 24 12 23 11
1 ATBC, Alpha-Tocopherol Beta-Carotene Cancer Prevention Study; HPFS, Health Professionals Follow-Up Study; NLCS, Netherlands Cohort Study;
NYSC, New York State Cohort; CNBSS, Canadian National Breast Screening Study; IWHS, Iowa Women’s Health Study; NHS-A and NHS-B, Nurses’ Health
Study Section A and Section B, respectively.
2 By current smokers.
3 x  SD (all such values).
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TABLE 3
Alcohol consumption (g/d) and lung cancer: study-specific and pooled multivariate-adjusted relative risks (RR)1
Alcohol consumption (g/d)
P for
trend
P for between-studies
heterogeneity for
30 g alcohol/d
categoryNone 0 to5 5 to 15 15 to30 30
Men
Alpha-Tocopherol Beta-Carotene Cancer
Prevention Study
No. of cases 45 61 79 60 53 0.59
RR 1.0 0.82 0.87 0.81 0.83
95% CI — 0.56, 1.22 0.60, 1.27 0.54, 1.20 0.55, 1.26
Health Professionals Follow-Up Study
No. of cases 51 41 67 18 67 0.10
RR 1.0 0.80 0.97 0.51 1.26
95% CI — 0.53, 1.21 0.67, 1.40 0.29, 0.87 0.86, 1.84
Netherlands Cohort Study
No. of cases 111 136 200 193 188 0.01
RR 1.0 1.11 1.20 1.10 1.69
95% CI — 0.78, 1.57 0.86, 1.66 0.79, 1.54 1.18, 2.44
New York State Cohort
No. of cases 47 135 86 53 71 0.01
RR 1.0 0.73 0.95 0.85 1.16
95% CI — 0.52, 1.02 0.66, 1.36 0.57, 1.26 0.80, 1.70
Pooled
No. of cases 254 373 432 324 379 0.03 0.09
RR 1.0 0.86 1.00 0.83 1.21
95% CI — 0.71, 1.03 0.84, 1.20 0.62, 1.10 0.91, 1.61
Pooled2
No. of cases 110 184 228 158 197 0.02 0.04
RR 1.0 0.99 1.18 1.01 1.48
95% CI — 0.76, 1.28 0.86, 1.62 0.77, 1.31 0.96, 2.29
Women
Canadian National Breast Screening Study
No. of cases 32 42 28 19 28
RR 1.0 0.96 0.71 0.83 1.12 0.65
95% CI — 0.57, 1.62 0.39, 1.26 0.43, 1.59 0.59, 2.13
Iowa Women’s Health Study
No. of cases 197 79 57 31 69
RR 1.0 0.74 0.78 1.03 1.49 0.01
95% CI — 0.57, 0.96 0.58, 1.05 0.70, 1.51 1.11, 2.00
Netherlands Cohort Study
No. of cases 43 30 24 22 9
RR 1.0 0.59 0.57 0.77 0.56 0.55
95% CI — 0.34, 1.01 0.31, 1.07 0.38, 1.54 0.21, 1.45
New York State Cohort
No. of cases 25 66 19 12 8
RR 1.0 0.91 0.89 0.85 1.04 0.99
95% CI — 0.57, 1.45 0.48, 1.64 0.42, 1.74 0.46, 2.38
Nurses’ Health Study
Section A
No. of cases 50 40 32 11 23
RR 1.0 0.77 0.64 0.63 0.99 0.99
95% CI — 0.50, 1.17 0.41, 1.00 0.32, 1.21 0.59, 1.65
Section B
No. of cases 120 87 92 35 45
RR 1.0 0.81 1.04 1.03 1.07 0.32
95% CI — 0.61, 1.06 0.79, 1.37 0.70, 1.51 0.75, 1.52
Pooled
No. of cases 467 344 252 130 182
RR 1.0 0.78 0.81 0.92 1.16 0.03 0.35
95% CI — 0.67, 0.91 0.68, 0.97 0.74, 1.13 0.94, 1.43
Pooled2
No. of cases 297 211 163 90 108
RR 1.0 0.78 0.84 1.00 1.06 0.16 0.56
95% CI — 0.65, 0.94 0.69, 1.03 0.77, 1.29 0.83, 1.35
1 Adjusted for education (high school graduate, high school graduate, orhigh school graduate), BMI (23, 23 to25, 25 to30, or30; in kg/m2),
energy intake (continuous), smoking status (never, past, or current), smoking duration for past and current smokers (continuous), and cigarettes smoked daily
for current smokers (continuous).
2 Excluding first 4 y of follow-up.
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Risks associated with specific beverages are shown in Table
4. For these analyses, because of the small numbers of heavy
drinkers of a single beverage, the upper category was collapsed
to those drinking15 g alcohol of that beverage daily. There was
significant between-studies heterogeneity for sex in the15 g/d
category for alcohol from beer (P 0.004) and spirits (P 0.03)
but not from wine (P 0.24) (data not shown). In men, there was
no increase in risk associated with alcohol from beer. For alcohol
from wine, there was evidence of decreased risk (pooled multi-
variate RR: 0.87; 95% CI: 0.55, 1.39; P for trend 0.04). When
men drinking15 g alcohol/d from spirits were compared with
those who drank no spirits, the pooled multivariate RR was1.34
(95% CI: 1.09, 1.66; P for trend  0.04). Because there were
many cases in the consumption category of15 g alcohol/d, we
also examined the risk of lung cancer in men who consumed 15
to30 (pooled multivariate RR: 1.15; 95% CI: 0.87, 1.51) and
30 (pooled multivariate RR: 1.65; 95% CI: 1.19, 2.27) g alco-
hol/d from spirits (P for trend  0.012; data not shown). There
was significant heterogeneity among men in the associations of
the 3 beverage types with risk of lung cancer (P  0.03 for
consumption of15 g alcohol/d). In women, among those drink-
ing15 g alcohol from beer/d, the pooled multivariate RR was
1.88 (95% CI: 1.45, 2.42; P for trend 0.001). The CIs included
the null for the other 2 beverages for the upper category RR
estimates. For women, the P value for heterogeneity among the
3 beverages in the upper category of consumption was  0.01.
Separate data on the consumption of red and white wine were
available for a subset of studies; these separate results were
similar to those shown for total wine consumption by both men
and women (data not shown).
RRs for lung cancer stratified by smoking status are shown in
Table 5. The ATBC Study had no participants who were never
or former smokers, and thus it was not included in analyses for
those categories. The Canadian National Breast Screening Study
and the New York State Cohort were not included in the highest
drinking category for never smokers because of insufficient sam-
ple size, but they were included in the other categories. Also in
these analyses, because of limitations of sample size, the highest
category of consumption was 15 g alcohol/d. There was sig-
nificant (P 0.01) heterogeneity between studies in the stratum
of nonsmokers by sex but not among the current and former
smokers (data not shown). In male never smokers, the risk of lung
cancer was greater in the consumption category of 15 g alco-
hol/d than in the category of no alcohol consumption (pooled
multivariate RR: 6.38; 95% CI: 2.74, 14.9; P for trend 0.001).
In the same comparison in the women, the increase was more
TABLE 4
Risk of lung cancer associated with alcohol consumption from beer, wine, and spirits by sex: pooled multivariate-adjusted relative risks (RR)1
Alcohol consumption (g/d)
P for
trend
P for between-studies
heterogeneity in
15 g alcohol/d
category
P for between-studies
heterogeneity due to
beverage type in
15 g alcohol/d
categoryNone 0 to5 5 to 15 15
Men
Beer
No. of cases 613 412 227 118
RR 1.0 0.90 0.82 1.10 0.47 0.47
95% CI — 0.77, 1.05 0.67, 0.99 0.85, 1.42
Wine
No. of cases 861 348 103 58
RR 1.0 0.94 0.66 0.872 0.04 0.23
95% CI — 0.80, 1.11 0.51, 0.87 0.55, 1.39
Spirits
No. of cases 435 304 271 360
RR 1.0 1.17 1.00 1.34 0.04 0.28 0.03
95% CI — 0.98, 1.40 0.83, 1.21 1.09, 1.66
Women
Beer
No. of cases 947 122 102 74
RR 1.0 0.75 1.18 1.88 0.001 0.43
95% CI — 0.62, 0.92 0.95, 1.46 1.45, 2.42
Wine
No. of cases 699 379 100 67
RR 1.0 0.87 0.75 1.09 0.99 0.31
95% CI — 0.72, 1.05 0.52, 1.07 0.78, 1.51
Spirits
No. of cases 768 224 138 115
RR 1.0 0.86 0.77 0.99 0.52 0.56 0.01
95% CI — 0.73, 1.00 0.56, 1.06 0.80, 1.22
1 Adjusted for education (high school graduate, high school graduate, orhigh school graduate), BMI (23, 23 to25, 25 to30, or30; in kg/m2),
energy intake (continuous), smoking status (never, past, or current), smoking duration for past and current smokers (continuous), and cigarettes smoked daily
for current smokers (continuous). Each analysis is also adjusted for consumption of the other 2 beverages (eg, beer is also adjusted for wine and spirits).
2 The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study had no cases in the15 g alcohol/d category and was not included in this category but
was included in the 2 lower categories.
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modest and the CI included the null (pooled multivariate RR:
1.35; 95% CI: 0.64, 2.87; P for trend  0.98), but the estimate
was based on only 8 cases in the highest category, and 2 of the
cohorts had no cases in that category. In both male and female
former smokers, alcohol consumption was not associated with
risk of lung cancer.
We also examined risk associated with alcohol consumption in
former smokers who had quit smoking10 y before the baseline.
There was no association between alcohol consumption and risk
in this group (data not shown). For current smokers, upper-
category pooled multivariate RRs were 0.94 and 1.10 for men
and women, respectively, and CIs included the null (P for trend
were  0.92 and 0.02, respectively). When we examined the
association between alcohol consumption and lung cancer risk in
current smokers who reported smoking20 cigarettes/d at base-
line, we found no association. The association between alcohol
consumption and lung cancer risk was modified by smoking
status in men but not in women (P 0.001 and 0.76, respec-
tively, for between-studies heterogeneity by smoking status in
the upper category of alcohol consumption). We also examined
beverage-specific analyses stratified by smoking status; the
number of cases in each category was small, and the CIs were
wide. Whereas there was evidence of an inverse association with
wine consumption in men in the overall group, when results were
TABLE 5
Alcohol consumption and lung cancer by smoking status: pooled multivariate-adjusted relative risks (RR)
Alcohol consumption (g/d)
P for
trend
P for between-studies
heterogeneity for
15 g alcohol/d
category
P for between-studies
heterogeneity due to
smoking status for
15 g alcohol/d
categoryNone 0 to5 5 to15 15
Men
Nonsmokers1
No. of cases 10 16 18 30 0.001 0.51
RR 1.02 1.49 2.53 6.38
95% CI — 0.64, 3.49 1.10, 5.81 2.74, 14.90
Former smokers1
No. of cases 99 139 161 236 0.27 0.91
RR 1.02,3 0.72 0.87 0.94
95% CI — 0.54, 0.98 0.65, 1.17 0.71, 1.25
Current smokers
No. of cases 145 218 253 437 0.92 0.22 0.001
RR 1.02,4 0.85 1.01 0.94
95% CI — 0.52, 1.38 0.75, 1.37 0.72, 1.24
Current smokers (20 cigarettes/d)
No. of cases 67 93 105 121 0.12 0.81
RR 1.02,4 0.83 1.01 0.76
95% CI — 0.42, 1.66 0.69, 1.47 0.53, 1.11
Women
Nonsmokers
No. of cases 90 68 17 8 0.98 0.52
RR 1.02 0.98 0.895 1.355,6
95% CI — 0.69, 1.37 0.52, 1.54 0.64, 2.87
Former smokers
No. of cases 112 82 72 72 0.26 0.19
RR 1.02,3 0.68 0.85 1.11
95% CI — 0.39, 1.16 0.59, 1.21 0.69, 1.79
Current smokers
No. of cases 265 194 163 232 0.02 0.62 0.76
RR 1.02,4 0.76 0.85 1.10
95% CI — 0.59, 0.97 0.69, 1.05 0.90, 1.33
Current smokers (20 cigarettes/d)
No. of cases 102 62 60 62 0.42 0.50
RR 1.02,4 0.61 0.79 0.94
95% CI — 0.43, 0.87 0.55, 1.12 0.66, 1.33
1 Does not include the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study, which was limited to current smokers.
2 Adjusted for education (high school graduate, high school graduate, orhigh school graduate), BMI (23, 23 to25, 25 to30, or30; in kg/m2),
and energy intake (continuous).
3 Also adjusted for smoking duration (continuous).
4 Also adjusted for smoking duration (continuous) and cigarettes smoked daily (continuous).
5 The Canadian National Breast Screening Study did not have any female nonsmokers in the 5 to 15 g alcohol/d and 15 g alcohol/d categories and
was not included in these categories but was included in the 2 lower categories.
6 The New York State Cohort did not have any female nonsmokers in the15 g alcohol/d category and was not included in this category but was included
in the 3 lower categories.
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stratified by smoking status, this inverse association was ob-
served only in former smokers (pooled multivariate RR: 0.54;
95% CI: 0.29, 1.01 for15 versus 0 g alcohol/d); for never and
current smokers, there was a nonsignificantly greater risk in
association with wine drinking (data not shown).
We examined risk by tumor histology (Table 6). In the highest
category of alcohol consumption, there was significant between-
studies heterogeneity by sex for small-cell carcinomas (P 
0.01) but not for adenocarcinomas and squamous cell carcino-
mas (data not shown). There was some evidence that alcohol
consumption was more strongly associated with the risk of ade-
nocarcinomas in both men and women and with the risk of small-
cell tumors in men. However, the difference in the RRs was not
significant; for men and women in the30 g alcohol/d category,
P for common effects according to cell type was 0.51 and 0.26,
respectively.
Residual confounding by smoking was a concern in our anal-
yses. We therefore examined the effect on results if all partici-
pants coded as never smokers were in fact former smokers. We
recalculated RRs after assigning all never smokers the study-
specific median duration of smoking reported by former smok-
ers. These RRs were quite similar to our original calculations; CIs
overlapped almost completely (data not shown). Because there
might be more misclassification in reported smoking status in the
heavier drinkers, we also examined a model in which we reclas-
sified as former smokers the never smokers in the upper category
of alcohol drinking. For this latter analysis, the RRs were closer
to the null than in the original analyses, and the CIs included the
null. Nonetheless, the P for trend was 0.05 for the men (data not
shown).
We also examined whether there were differences in risk as-
sociated with alcohol consumption for dichotomous strata of
fruit, -cryptoxanthin, folate and vitamin A consumption deter-
mined by their respective median values. There was no evidence
of heterogeneity in effects across strata (data not shown).
DISCUSSION
In this pooled analysis, there was weak evidence for a positive
association between alcohol consumption and lung cancer risk.
Trends were significant, although the CIs for the risk estimates in
the highest category of alcohol consumption included the null. In
men, the consumption of spirits was associated with risk more
than was that of other beverage types; in women, risk was asso-
ciated with the consumption of beer than with that of wine or
spirits. There was a strong positive association between alcohol
consumption and risk in never smoking men that was not ob-
served in female never smokers. However, the small number of
TABLE 6
Alcohol consumption (g/d) and lung cancer by histologic type: pooled multivariate-adjusted relative risks (RR)1
Alcohol consumption (g/d)
P for
trend
P for between-studies
heterogeneity for
30 g alcohol/d
category
P for common effect
by cell type for
30 g alcohol/d
categoryNone 0 to5 5 to 15 15 to30 30
Men
Adenocarcinoma
No. of cases 54 82 104 53 80 0.10 0.33
RR 1.0 1.06 1.24 1.00 1.44
95% CI — 0.79, 1.41 0.94, 1.62 0.69, 1.46 1.01, 2.06
Squamous cell
No. of cases 92 132 158 131 140 0.64 0.01
RR 1.0 0.91 0.98 0.81 1.05
95% CI — 0.70, 1.18 0.75, 1.29 0.55, 1.19 0.52, 2.12
Small cell
No. of cases 34 59 58 68 61 0.01 0.48 0.51
RR 1.0 1.10 1.15 1.08 1.65
95% CI — 0.80, 1.50 0.85, 1.56 0.79, 1.47 1.19, 2.29
Women
Adenocarcinoma
No. of cases 178 151 115 55 81 0.01 0.20
RR 1.0 0.92 0.92 0.96 1.40
95% CI — 0.75, 1.13 0.73, 1.15 0.72, 1.30 0.98, 1.98
Squamous cell
No. of cases 86 58 45 21 31 0.99 0.15
RR 1.0 0.72 0.76 0.80 0.922
95% CI — 0.49, 1.06 0.57, 1.03 0.55, 1.18 0.55, 1.54
Small cell
No. of cases 90 58 50 28 30 0.94 0.79 0.26
RR 1.0 0.81 0.77 0.99 0.89
95% CI — 0.61, 1.05 0.56, 1.06 0.63, 1.54 0.62, 1.29
1 Adjusted for education (high school graduate, high school graduate, orhigh school graduate), BMI (23, 23 to25, 25 to30, or30; in kg/m2),
energy intake (continuous), smoking status (never, past, or current), smoking duration for past and current smokers (continuous), and cigarettes smoked daily
for current smokers (continuous).
2 The New York State Cohort did not have any cases of squamous cell carcinomas among females in the30 g alcohol/d category and was not included
in this category but was included in the 4 lower categories.
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female cases who were never smokers in the highest drinking
category limited our ability to examine associations in this group.
There was no evidence of an association of alcohol consumption
with risk in smokers, who constitute the largest portion of cases
in these cohorts.
Several potential mechanisms have been proposed for an ef-
fect of alcohol on lung cancer. These include carcinogenesis by
the alcohol metabolite acetaldehyde (3), oxidation by alcohol
(4–12), and induction by alcohol of cytochrome p450 that affects
the metabolism of other procarcinogens (4, 13). Other com-
pounds in alcoholic beverages may also be relevant (2), which
could explain the different associations we saw for beer and
spirits than for wine. However, we saw differences in beverage-
specific associations in both men and women; the observed
beverage-specific differences may not be biological. Further-
more, it has been hypothesized that the mechanism of alcohol
may be to enhance carcinogenic effects of cigarette smoke on
tissues (2); our findings were strongest for nonsmokers, how-
ever, which would not be consistent with this explanation.
Many epidemiologic studies have examined the association
between alcohol consumption and lung cancer, and the results
have been inconsistent (2), perhaps as a result of the strong effect
of smoking on lung cancer risk, the likely weak effect (if any) of
alcohol, and the different sizes of the studies. In a meta-analysis
of studies of alcohol consumption and lung cancer (22), point
estimates for combined findings in 13 cohorts [including 2 of the
cohorts in our pooled analyses (31, 48)] were similar to those we
report here. These investigators also conducted a meta-analysis
of 10 case-control studies; there was an increase in lung cancer
risk associated with alcohol consumption in hospital-based but
not population-based case-control studies (22). In 2 cohort stud-
ies not included in our analysis (49, 50) and in several case-
control studies (51–53) published since the publication of the
meta-analysis, findings were also consistent with ours.
Because smoking is such a strong risk factor for lung cancer
and because smoking is correlated with alcohol consumption, the
major concern in the examination of an association between
alcohol consumption and lung cancer is failure to fully control for
confounding by smoking. Measurement error in measured as-
pects of smoking (ie, smoking status, duration of smoking, and
amount smoked) and variations in other unmeasured aspects (ie,
depth of inhalation and length of time that smoke is held in the
lungs) may have an effect on the estimation of the risk of lung
cancer from other factors correlated with smoking, such as alco-
hol (2, 22, 54). Itmaybethatourfindingsofdifferencesbybeverage
type may be the result of uncontrolled confounding. Of interest with
respect to residual confounding by smoking is our finding of a large
increase inriskof lungcancer inmenwhoneversmoked.Therehave
been several other studies of alcohol consumption and lung cancer
in nonsmokers (22, 55–58). Most of these studies have found an
increased risk associated with alcohol consumption, albeit gen-
erally at somewhat lower levels of alcohol consumption.
By contrast with the findings of increased risk in male never
smokers, we found little evidence of increased risk in former and
current smokers in our study, even in those who had quit smoking
10 y before or for current smokers of20 cigarettes/d, groups
that should be more similar to the never smokers with respect to
their lung cancer risk. There was some evidence that female
current smokers in the highest category of alcohol consumption
were at increased risk. Whereas the CI for the highest category
included the null, there was evidence of a significant trend in the
data. Other studies have reported increased risk with alcohol
consumption in heavy smokers (2, 59, 60).
Because of our finding of increased risk of lung cancer with
alcohol consumption in men who reported never smoking, we
investigated the possible effect of a misreporting of smoking
status on the estimate of risk by recalculating risk estimates after
reclassifying never smokers as former smokers. Risk estimates
changed only somewhat. In contrast, in simulations regarding
misclassification by smoking status, Korte et al (22) found that
the RR for their meta-analysis of cohort studies was consistent
with no true effect, 10% misclassification of smokers as non-
smokers, and no misclassification of drinking status.
An additional potential source of residual confounding could
be the effect of passive smoke exposure. In particular, the group
of nonsmokers who were included in the highest category of
alcohol consumption might have a heavier exposure to smoke if
they drank in smoke-filled environments. We had limited or no
information on passive smoke exposure in all but one of the
cohorts. However, passive smoke exposure is unlikely to explain
an association of the magnitude of that observed in nonsmoking
men. Furthermore, there may be some confounding due to the
smoking of pipes and cigars. Limited information was available
on the smoking of pipes and cigars in the current study.
Misclassification of drinking status—particularly the inclu-
sion of former drinkers in those reporting that they are currently
nondrinkers—is another potential source of bias. Misclassifica-
tion of this nature would attenuate risk estimates if alcohol con-
sumption does increase lung cancer risk. In fact, there was some
indication in both men and women that there was a lower risk of
cancer in those reporting moderate consumption than in non-
drinkers. Our findings were also consistent with an alcohol effect
limited to heavier drinking. Because of smaller numbers of
heavier drinkers, we were not able to explore in detail the asso-
ciations with heavy alcohol consumption.
We found some evidence of differences in the association
between different beverage types and the risk of lung cancer: a
stronger association for spirits in men and for beer in women.
Other studies have found greater risk in association with con-
sumption of beer and spirits but not wine (2). These differences
may be related to compounds found in beer or spirits. When we
looked at more closely defined categories of the consumption of
spirits by the men, the increased risk was again primarily con-
fined to those drinking30 g alcohol/d.
In this study, which entailed pooling data from the cohorts of
7 studies with a total sample of nearly 400 000 participants and
3000 lung cancer cases, we found weak evidence of a positive
association between alcohol consumption and lung cancer risk.
By pooling data from these large cohort studies, we were able to
examine risk in uniformly defined exposure groups and with a
consistent group of covariates. The observed risk appeared to be
confined to those subjects with consumption of30 g alcohol/d,
which corresponds to2 drinks/d. However, we could not exclude
the possibility, at least in the smokers, that this association could be
explained by uncontrolled confounding by smoking. The finding of
an increased RR in male never smokers is notable, although the
absolute risk of lung cancer in this group is, of course, small. Smok-
ing remains the most important cause of this disease, which has
considerable effect on public health.
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Pooled data came from existing cohorts. Investigators for each study had
contributed to the design of and data collection and analysis of their particular
study.
When these analyses were initiated, DJH was the principal investigator for
the Pooling Project, leading the overall effort to conduct data analysis on
existing data sets. SAS-W (the current principal investigator for the Pooling
Project) worked with JLF, DJH, and JR on management of the data and in all
phases of data analysis and manuscript writing. The data analysis plan was
conceived by JLF. Data analyses were conducted by JR. All other authors
contributed to the data analysis plan. The manuscript was written by JLF with
input from all of the other authors. None of the authors had a personal or
financial conflict of interest.
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